Shishehbor, M. H., White, C. J., Beckman, J. A., Misra, S., Schneider, P. A., Lookstein, R. A., … Jaff, M. R. (2018). Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vasc Med, 23(6), 558–559. https://doi.org/10.1177/1358863X18802969

Shishehbor, Mehdi H., Christopher J. White, Joshua A. Beckman, Sanjay Misra, Peter A. Schneider, Robert A. Lookstein, Vikram S. Kashyap, et al. “Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.” Vasc Med 23, no. 6 (December 2018): 558–59. https://doi.org/10.1177/1358863X18802969.

Shishehbor MH, White CJ, Beckman JA, Misra S, Schneider PA, Lookstein RA, et al. Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vasc Med. 2018 Dec;23(6):558–9.

Shishehbor, Mehdi H., et al. “Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.” Vasc Med, vol. 23, no. 6, Dec. 2018, pp. 558–59. Pubmed, doi:10.1177/1358863X18802969.

Shishehbor MH, White CJ, Beckman JA, Misra S, Schneider PA, Lookstein RA, Kashyap VS, Clair D, Jones WS, Rosenfield K, Katzen BT, Jaff MR. Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vasc Med. 2018 Dec;23(6):558–559.